Radcliffe Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-102,974
| Closed | -$1.03M | – | 961 |
|
|
2022
Q3 | $1.03M | Hold |
102,974
| – | – | 0.02% | 887 |
|
|
2022
Q2 | $1.02M | Hold |
102,974
| – | – | 0.02% | 930 |
|
|
2022
Q1 | $1.02M | Buy |
102,974
+2,974
| +3% | +$29.3K | 0.02% | 920 |
|
|
2021
Q4 | $976K | Hold |
100,000
| – | – | 0.03% | 840 |
|
|
2021
Q3 | $978K | Hold |
100,000
| – | – | 0.03% | 693 |
|
|
2021
Q2 | $985K | Hold |
100,000
| – | – | 0.03% | 723 |
|
|
2021
Q1 | $998K | Hold |
100,000
| – | – | 0.04% | 582 |
|
|
2020
Q4 | $1.01M | Buy |
+100,000
| New | +$1.01M | 0.06% | 206 |
|